Atrion Corp (ATRI) - מכפיל מחיר להכנסות עתידי

The forward P/S based on forecasts demonstrates stable demand for Atrion Corporation (ATRI) cardiology and infusion products, where the value of 4.40 characterizes this level. Atrion Corporation (ATRI) is creating an ecosystem of high-precision components integrated into the OEM projects of B2B partners. Business resilience is supported by the control of polymer supplies and clinic demand for anesthesiology tubes while maintaining a healthy operating margin.

For Atrion Corporation (ATRI), whose long-term contracts in the medical systems niche guarantee a stable cash flow, the forward P/S based on forecasts reflects the market value of one dollar of expected revenue. This chart demonstrates a balance between the premium for high customer stickiness and the risks of overpaying for future growth, confirming the fundamental resilience of the business during periods of macroeconomic factor revaluation.